Integral Diagnostics | IDX - Gross Profit On Sales

Stock Price
2.30
Daily Change
0.04 1.77%
Monthly
-0.43%
Yearly
7.98%
Q2 Forecast
2.20

Integral Diagnostics reported AUD226.91M in Gross Profit on Sales for its fiscal semester ending in June of 2024.





Gross Profit On Sales Change Date
Alcidion AUD 21.02M 5.65M Dec/2025
Ansell USD 326.2M 27.6M Jun/2024
Cochlear AUD 856.8M 430M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Healius AUD 554.4M 415.55M Dec/2024
Mayne Pharma AUD 86.13M 18.92M Jun/2025
Monash IVF AUD 110.44M 89.18M Dec/2025
Nanosonics AUD 78.01M 3.95M Dec/2025
Polynovo AUD 61.26M 38M Dec/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 886.53M 65.71M Dec/2025
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025